Core Viewpoint - MRDIMM is a new memory module architecture designed for high-performance computing and data-intensive applications, achieving a data transfer rate of 8800 MT/s, which is nearly a 40% increase in peak bandwidth compared to standard DDR5 RDIMM [1][2] Group 1: MRDIMM Technology Overview - MRDIMM is suitable for high-performance computing and artificial intelligence applications, addressing the bandwidth decline per core due to the increasing number of processor cores [2] - The first generation of MRDIMM supports a data transfer rate of 8800 MT/s, with the third generation expected to reach 14000 MT/s [2] - The architecture of MRDIMM includes 1 MRCD (Memory Register Clock Driver) and 10 MDB (Memory Data Buffer) chips, indicating significant growth potential in the market [3] Group 2: Market Demand Projections - By 2030, the demand for MRCD and MDB is projected to increase significantly, with estimates under pessimistic, neutral, and optimistic scenarios suggesting demand for MRCD could reach 274 million, 456 million, and 593 million units respectively, while MDB demand could reach 2.736 billion, 4.560 billion, and 5.928 billion units [4] - The penetration rates for MRDIMM are estimated to be 30%, 50%, and 65% under pessimistic, neutral, and optimistic scenarios respectively [4] Group 3: Industry Implications - The adoption of MRDIMM technology is expected to drive demand for MRCD and MDB chips, particularly as it becomes compatible with Intel's sixth-generation CPUs [1][3] - Key companies in the market include 澜起科技 (Lanke Technology) and 聚辰股份 (Juchen Technology), which are involved in the production of MRCD/MDB chips and DDR5 memory modules respectively [1]

1 、 《 PEEK材料产业链梳理，下一个千亿级赛道？ 》摘要 ■ PEEK的自润滑性和耐高温性能使其成为机器人驱动系统中的理想材料，减少摩擦和噪音，延长使 用寿命。 ■ 由于其优异的耐热、绝缘及耐腐蚀性，PEEK适合用于电子设备的支撑结构，尤其是在特殊环境下 工作的机器人中，如医疗和航天机器人。 ■ PEEK的核心原料是二氟二苯甲酮（DFBP），这类原料的生产技术掌握在少数企业手中，全球产能 集中度高。 2、 《 宠物经济虽热，难掩动物保健行业颓势 》摘要 ■ 2024年中国的宠物市场规模预计突破3000亿元，且宠物用药对安全性和有效性有更高要求，尤其 是猫三联和犬四联疫苗的国产化进程正在加速。 ■ 瑞普生物在宠物用疫苗领域表现突出，特别是打破了进口品牌对猫三联疫苗的垄断，取得了一定的 市场份额。 ■ 大型养殖集团如温氏股份、牧原股份等已经开始布局兽药和疫苗业务，这使得独立的动物保健企业 面临着前所未有的压力。 ■ 随着大型养殖企业自建兽药产能，并通过集中采购提高议价能力，独立兽药公司的市场空间将被进 一步压缩。 3、 《 关税战，先把宠物经济"打爆了" 》摘要 ■ 乖宝宠物通过高效的成本管控和规模效应，推 ...

Investment Rating - The report maintains a "Buy-A" rating for the company [2][7] Core Views - The company has shown significant growth in revenue and net profit, with a 46.17% year-on-year increase in revenue to 1.028 billion yuan and a 189.23% increase in net profit to 290 million yuan for the year 2024 [3][4] - The growth is attributed to the rapid increase in shipments of SPD products and automotive-grade EEPROM, driven by strong downstream demand [4][5] - The company's gross margin improved to 54.81%, up 8.22 percentage points year-on-year, while the net margin reached 26.84%, an increase of 15.08 percentage points [5] Financial Performance - For 2024, the company achieved a revenue of 1.028 billion yuan, a 46.17% increase from the previous year, and a net profit of 290 million yuan, up 189.23% [3][4] - The fourth quarter of 2024 saw a revenue of 259 million yuan, a 28.45% year-on-year increase, and a net profit of 79 million yuan, reflecting a 339.79% increase [3][4] - The company’s gross margin for 2024 was 54.81%, and the net margin was 26.84%, indicating improved profitability [5] Product Development - The company is expanding its product lines, focusing on high-value markets such as SPD products for DDR5 memory modules, automotive-grade EEPROM, and NOR Flash for various applications [6] - The successful introduction of automotive-grade EEPROM to leading Tier 1 suppliers has significantly boosted sales [4][6] Future Projections - The company is projected to achieve earnings per share (EPS) of 2.74 yuan in 2025, 3.83 yuan in 2026, and 4.81 yuan in 2027, with corresponding price-to-earnings (P/E) ratios of 26.5, 19.0, and 15.1 [7][9] - Revenue is expected to grow to 1.497 billion yuan in 2025, 2.010 billion yuan in 2026, and 2.476 billion yuan in 2027, reflecting a strong growth trajectory [9][13]